Recombinant Human DBI, His tagged

• Cat.No.: DBI-113H
• Product Overview: Recombinant Human DBI (P07108-2) (Met1-Ala87), fused with a polyhistidine tag at the N-terminus, was produced in E. coli.

Specification

• Source: E. coli
• Species: Human
• Tag: His
• Predicted N Terminal: His
• Form: Lyophilized from sterile PBS, pH 7.4.Normally 5 % - 8 % trehalose and mannitol are added as protectants before lyophilization.
• Molecular Mass: The recombinant human DBI consists of 122 amino acids and predicts a molecular mass of 14 KDa. It migrates as an approximately 18 KDa band in SDS-PAGE under reducing conditions.
• Endotoxin: < 1.0 eu per μg of the protein as determined by the LAL method.
• Purity: >95 % as determined by SDS-PAGE
• Stability: Samples are stable for up to twelve months from date of receipt at -70oC.
• Storage: Store it under sterile conditions at -20oC~-70oC. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
• Reconstitution: It is recommended that sterile water be added to the vial to prepare a stock solution. Centrifuge the vial at 4℃ before opening to recover the entire contents.

Gene Information

• Gene Name: DBI diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein) [ Homo sapiens ]
• Official Symbol: DBI
• Gene ID: 1622
• mRNA Refseq: NM_001079862
• Protein Refseq: NP_001073331
• MIM: 125950
• UniProt ID: P07108
• Chromosome Location: 2q12-q21